Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses

Keyphrases

• Very Virulent 100%
• Avian Influenza 100%
• H1N1 Virus 100%
• Virus 66%
• Virion 66%
• H7N9 66%
• H5N1 66%
• H1N1 66%
• Lethality Rate 66%
• High Titer 33%
• H5N1 Virus 33%
• China 33%
• Epizootic 33%
• Mathematical Modeling 33%
• In Vitro Infection 33%
• Growth Properties 33%
• Infection Rate 33%
• A549 Cells 33%
• Severe Infection 33%
• Growth Kinetics 33%
• Fast Rates 33%
• Permissiveness 33%
• Kinetic Experiments 33%
• Significant Loss 33%
• Low Pathogenic 33%
• H5N1 Influenza Virus 33%
• Differential Growth 33%
• Slow Growth 33%
• Replication Kinetics 33%
• H7N9 Influenza Virus 33%
• Viral Kinetics 33%
• H1N1 Influenza Virus 33%
• Pandemic Strains 33%
• Pandemic (H1N1) 2009 33%
• Neuraminidase Inhibitors 33%
• H7N9 Virus 33%
• Inhibitor Resistance 33%
• Eclipse Phase 33%
• Neuraminidase Activity 33%

Immunology and Microbiology

• Influenza A Virus (H1N1) 100%
• Avian Influenza Virus 100%
• Infection 100%
• Influenza A Virus (H5N1) 80%
• Influenza A Virus (H7N9) 80%
• Virus 60%
• Virion 40%
• Replication 40%
• Pathogenicity 20%
• Titer 20%
• Influenza 20%
• Aves 20%
• In Vitro 20%
• Neuraminidase Inhibitor 20%